Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease.

scientific article

Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ATHEROSCLEROSIS.2014.04.010
P932PMC publication ID4102310
P698PubMed publication ID24819748
P5875ResearchGate publication ID262195333

P50authorEric RimmQ59660391
Murray A. MittlemanQ87967265
Kenneth J. MukamalQ99254177
John P. CookeQ38320291
Michel M JoostenQ40849754
P2093author name stringJennifer K Pai
Monica L Bertoia
P2860cites workConfounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal functionQ23912481
Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals.Q52011407
Serum Folate and Risk of Fatal Coronary Heart DiseaseQ56171251
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseQ57268055
Dietary fat and the risk of breast cancerQ69671119
Validity of self-reported waist and hip circumferences in men and womenQ70275947
Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive diseaseQ71106430
Folic acid fortification of the food supply. Potential benefits and risks for the elderly populationQ71899823
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyQ72030504
Vitamin status and intake as primary determinants of homocysteinemia in an elderly populationQ72305071
Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patientsQ73497114
Plasma homocysteine levels and mortality in patients with coronary artery diseaseQ73520715
The use of B vitamin supplements and peripheral arterial disease risk in men are inversely relatedQ73886238
Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine StudyQ74196327
Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal womenQ77319712
Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial diseaseQ77927279
Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteineQ80345318
Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjectsQ80836575
Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adultsQ83691242
Impact of folic acid fortification of the US food supply on the occurrence of neural tube defectsQ28202223
The protective effects of estrogen on the cardiovascular systemQ33654314
Efficacy of folic acid supplementation in stroke prevention: a meta-analysisQ34004505
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individualsQ34142959
Peripheral arterial disease--epidemiological aspectsQ34492461
Endothelial function, vascular reactivity and gender differences in the cardiovascular systemQ34541879
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trialsQ34571592
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidenceQ35203190
Folate, homocysteine, endothelial function and cardiovascular diseaseQ35670845
Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trialsQ35816359
B-vitamins, homocysteine metabolism and CVD.Q36098211
Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.Q37373835
Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of AtherosclerosisQ37439379
Homocysteine and peripheral arterial disease: systematic review and meta-analysisQ37533752
Reproducibility and Validity of an Expanded Self-Administered Semiquantitative Food Frequency Questionnaire among Male Health ProfessionalsQ39605930
Prospective study of alcohol consumption and risk of coronary disease in men.Q41134811
Randomized clinical trial of folate supplementation in patients with peripheral arterial disease.Q43293498
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial diseaseQ43614603
Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam studyQ43634132
Decreased rate of coronary restenosis after lowering of plasma homocysteine levelsQ43834213
Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status.Q44123981
Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarctionQ44359631
Risk factors for progression of peripheral arterial disease in large and small vesselsQ44725766
Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow-up studyQ44836422
Plasma adiponectin levels and risk of myocardial infarction in men.Q44843420
Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males.Q46061346
Vitamins C, E and A and heme oxygenase in rats fed methyl/folate-deficient dietsQ46162793
Reproducibility and validity of a self-administered physical activity questionnaireQ46784319
Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated riskQ46786274
Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphismQ46870292
Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjectsQ46878256
Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.Q50539803
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.Q51518860
Sex-related differences in methionine metabolism and plasma homocysteine concentrations.Q51555480
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.Q51558185
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.Q51568729
A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.Q51571427
P433issue1
P921main subjectvitamin BQ183206
P304page(s)94-101
P577publication date2014-04-28
P1433published inAtherosclerosisQ4813570
P1476titlePlasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease
P478volume235

Reverse relations

cites work (P2860)
Q36029791A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.
Q36640299Adropin is associated with hyperhomocysteine and coronary atherosclerosis
Q48239148Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults.
Q100386589Cysteine and homocysteine as biomarker of various diseases
Q38689595Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective Studies
Q39464695Dietary choline and betaine; associations with subclinical markers of cardiovascular disease risk and incidence of CVD, coronary heart disease and stroke: the Jackson Heart Study.
Q40385266Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study
Q34482202Effects of choline on health across the life course: a systematic review
Q48267577Genome-wide association study of homocysteine in African Americans from the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Coronary Artery Risk in Young Adults study
Q42208511Homocysteine Induces Apoptosis of Human Umbilical Vein Endothelial Cells via Mitochondrial Dysfunction and Endoplasmic Reticulum Stress
Q64994317Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population.
Q85352634Plasma Homocysteine Levels Predict the Risk of Acute Cerebral Infarction in Patients with Carotid Artery Lesions
Q39629758Plasma Homocysteine and Prognosis of Acute Ischemic Stroke: a Gender-Specific Analysis From CATIS Randomized Clinical Trial.
Q35001518Role of betaine in improving the antidepressant effect of S-adenosyl-methionine in patients with mild-to-moderate depression